Vitamin E and Cardiovascular Disease: Observational Studies

  title={Vitamin E and Cardiovascular Disease: Observational Studies},
  author={J Michael Gaziano},
  journal={Annals of the New York Academy of Sciences},
  • J. Gaziano
  • Published 1 December 2004
  • Biology
  • Annals of the New York Academy of Sciences
Abstract: Basic research suggests that oxidative stress may play an important role in many chronic diseases and provides plausible mechanisms by which natural antioxidants such as vitamin E may delay or prevent steps in atherogenesis. Dietary research has shown that those who consume higher amounts of fruits and vegetables have lower rates of heart disease and stroke, raising the possibility that antioxidants are protective. Results from large‐scale human observational studies suggest that… 
The Role of Antioxidant Vitamins in Cardiovascular Disease
Data from randomized clinical trials do not support the use of antioxidant vitamins in cardiovascular disease, and antioxidant vitamins should not be recommended to patients for prevention or treatment of cardiovascular disease.
Antioxidants, oxidative stress, and cardiovascular diseases : cross-cultural comparisons and prospective cohort studies
The findings on beta-carotene support previous observational studies suggesting that this carotenoid relates to a lower CVD risk, and may partly contribute to the low observed CHD mortality.
Micronutrient Vitamin Deficiencies and Cardiovascular Disease Risk: Advancing Current Understanding
Although MVD is a significant risk factor for CVDs, supplementation with single or paired micronutrients for primary prevention of CVDS in healthy adults with no special nutritional needs is discouraged; there is insufficient evidence to determine the benefit/harm of such supplementation.
Nutrition and Stroke Prevention Cholesterol and Animal Fat Emerging Therapies
Current issues that warrant discussion in this venue include the intake of animal fat and cholesterol, the Cretan Mediterranean diet, the failure of most studies to show benefit of supplements with antiox-idant vitamins such as vitamins E and C, and the current controversy over failure of recent clinical trials to show reduction of stroke and other cardiovascular events by lowering plasma total homocysteine.
Mitochondria as possible pharmaceutical targets for the effects of vitamin E and its homologues in oxidative stress-related diseases.
It is concluded in this large pooled prospective study, in which long-term vitamin E supplementation was associated with lower ALS rates, and therefore, a possible protective effect of vitamin E deserves further consideration.
Dietary Approaches that Delay Age-Related Diseases
The best diet to delay age-related disease onset is one low in calories and saturated fat and high in wholegrain cereals, legumes, fruits and vegetables, and which maintains a lean body weight.
Nutrition and Stroke Prevention
A Cretan Mediterranean diet, which is high in beneficial oils, whole grains, fruits, and vegetables and low in cholesterol and animal fat, has been shown to reduce stroke and myocardial infarction by 60% in 4 years compared with the American Heart Association diet.
Pharmacogenomics in prevention of diabetic cardiovascular disease: utilization of the haptoglobin genotype in determining benefit from vitamin E
  • A. LevyS. Blum
  • Biology, Medicine
    Expert review of cardiovascular therapy
  • 2007
Supporting clinical evidence and a mechanistic basis for utilizing a genetic marker, the haptoglobin genotype, in determining whether vitamin E therapy may or may not be beneficial for a given patient with diabetes are provided.
Natural antioxidants in land- and marine-based wild-type food risk reduction.
It is now widely accepted that fruits and vegetables are important dietary components responsible for maintenance of good health, however, molecular mechanisms of protective effects ofruits and vegetables have not been fully elucidated.


Vitamin E consumption and the risk of coronary heart disease in men.
Evidence is provided of an association between a high intake of vitamin E and a lower risk of coronary heart disease in men, and public policy recommendations with regard to the use ofitamin E supplements should await the results of additional studies.
Vitamin E supplementation and cardiovascular events in high-risk patients.
In patients at high risk for cardiovascular events, treatment with vitamin E for a mean of 4.5 years had no apparent effect on cardiovascular outcomes and there were no significant differences in the incidence of secondary cardiovascular outcomes or in death from any cause.
Dietary antioxidants and risk of myocardial infarction in the elderly: the Rotterdam Study.
The hypothesis that high dietary beta-carotene intakes may protect against cardiovascular disease is supported by the results of this observational study in the elderly population of the Rotterdam Study.
Alpha-Tocopherol Supplementation in Healthy Individuals Reduces Low-Density Lipoprotein Oxidation but Not Atherosclerosis: The Vitamin E Atherosclerosis Prevention Study (VEAPS)
The results are consistent with previous randomized controlled trials and extend the null results of vitamin E supplementation to the progression of IMT in healthy men and women at low risk for CVD.
Low Plasma Vitamins E and C Increased Risk of Angina in Scottish Men a
Low plasma vitamin E or adipose linoleate predisposes to angina, and smoking may increase the risk of angina by lowering plasma vitamin C levels in Scottish men.
Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: the Established Populations for Epidemiologic Studies of the Elderly.
Findings are consistent with those for younger persons and suggest protective effects of vitamin E supplements in the elderly and suggest vitamins E and C should be considered as a standalone treatment for cancer and heart disease respectively.
Plasma antioxidants and coronary heart disease: vitamins C and E, and selenium.
The evidence did not support the hypothesis that plasma antioxidants explain regional differences in CHD mortality, and selenium levels did not correlate with the reported mortality rates of CHD.
Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project.
In women and men at risk of having a cardiovascular event because of the presence of at least one major risk factor, low-dose aspirin given in addition to treatment of specific risk factors contributes an additional preventive effect, with an acceptable safety profile.